Education
About Us
Working with TipRanks
Follow Us
Keros Therapeutics, Inc. (KROS)
:KROS
Keros Therapeutics (KROS) Ownership Overview
22.46% Insiders
17.77% Mutual Funds
0.16% Other Institutional Investors
10.95% ETFs
48.67% Public Companies and
Individual Investors
The ownership structure of Keros Therapeutics (KROS) stock is a mix of institutional, retail, and individual investors. Approximately 28.88% of the company’s stock is owned by Institutional Investors, 22.46% is owned by Insiders, and 48.67% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Apr 11, 2025 | xxxxxxxxxxxxx | $9462056 | |
| Aug 15, 2024 | xxxxxxxxxxxxx | $11002500 | |
| Aug 15, 2024 | xxxxxxxxxxxxx | $11002500 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $182599 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $6137306 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,390,964 | Insider | 13.29% | 70,567,719 | |
| 1,849,231 | Institution | 4.56% | 24,206,434 | |
| 1,547,178 | Institution | 3.81% | 20,252,560 | |
| 1,505,413 | Institution | 3.71% | 19,705,856 | |
| 1,475,736 | Institution | 3.64% | 19,317,384 | |
| 1,226,412 | Insider | 3.02% | 16,053,733 | |
| 1,226,412 | Insider | 3.02% | 16,053,733 | |
| 753,302 | Institution | 1.86% | 9,860,723 | |
| 575,492 | Insider | 1.42% | 7,533,190 | |
| 437,570 | Institution | 1.08% | 5,727,791 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,547,178 | Institution | 3.81% | 20,252,560 | |
| 1,505,413 | Institution | 3.71% | 19,705,856 | |
| 437,570 | Institution | 1.08% | 5,727,791 | |
| 433,323 | Institution | 1.07% | 5,672,198 | |
| 426,300 | Institution | 1.05% | 5,580,267 | |
| 388,000 | Institution | 0.96% | 5,078,920 | |
| 350,534 | Institution | 0.86% | 4,588,490 | |
| 325,783 | Institution | 0.80% | 4,264,499 | |
| 324,443 | Institution | 0.80% | 4,246,959 | |
| 215,561 | Institution | 0.53% | 2,821,693 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,017,145 | Institution | 2.51% | 11,269,967 | |
| 831,119 | Institution | 2.05% | 10,879,348 | |
| 691,305 | Institution | 1.70% | 8,807,226 | |
| 558,720 | Institution | 1.38% | 6,190,618 | |
| 295,032 | Institution | 0.73% | 3,861,969 | |
| 214,440 | Institution | 0.53% | 2,807,020 | |
| 163,642 | Institution | 0.40% | 2,084,799 | |
| 139,477 | Institution | 0.34% | 1,545,405 | |
| 103,257 | Institution | 0.25% | 1,144,088 | |
| 41,290 | Institution | 0.10% | 540,486 |
FAQ
Who Owns Keros Therapeutics, Inc. (KROS)?
According to the latest TipRanks data, approximately 0.16% of the company's stock is held by institutional investors, 22.46% is held by insiders, and 48.67% is held by retail investors.
What percentage of Keros Therapeutics, Inc. (KROS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.16% of Keros Therapeutics, Inc. (KROS) stock is held by institutional investors.
What percentage of Keros Therapeutics, Inc. (KROS) stock is held by retail investors?
According to the latest TipRanks data, approximately 48.67% of Keros Therapeutics, Inc. (KROS) stock is held by retail investors.
Who owns the most shares of Keros Therapeutics, Inc. (KROS)?
ADAR1 Capital Management, LLC owns the most shares of Keros Therapeutics, Inc. (KROS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.